UBS Group’s Moolec Science SA Warrant MLECW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$106 Sell
7,098
-2,198
-24% -$46 ﹤0.01% 10095
2026
Q1
$242 Buy
+9,296
New +$181 ﹤0.01% 10006
2025
Q3
Sell
-1,072
Closed -$17 10696
2025
Q2
$17 Buy
+1,072
New +$15 ﹤0.01% 10129
2024
Q2
Sell
-10
Closed 9882
2024
Q1
$0 Hold
10
﹤0.01% 9758
2023
Q4
$0 Buy
10
+5
+100% ﹤0.01% 9679
2023
Q3
$0 Buy
+5
New ﹤0.01% 9777

Other funds holding MLECW

UBS Group's MLECW Position: Q2 2026 in Review

UBS Group reduced its Moolec Science SA Warrant (MLECW) stake by 24% in Q2 2026, selling an estimated $46 and leaving 7,098 shares worth $106. The position accounts for ﹤0.01% of the portfolio, ranked #10095.

UBS Group first reported a position in MLECW in Q3 2023 and has held it in 6 quarters since. The position peaked at $242 in Q1 2026. 16 funds tracked by Wall St. Rank hold MLECW as of Q2 2026.

  • UBS Group held 7,098 shares of Moolec Science SA Warrant worth $106 as of Q2 2026.
  • UBS Group sold 2,198 Moolec Science SA Warrant shares in Q2 2026, an estimated $46.
  • Moolec Science SA Warrant made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #10095 holding.
  • UBS Group first reported a position in Moolec Science SA Warrant in Q3 2023 and has held it in 6 quarters since.
  • UBS Group's Moolec Science SA Warrant position peaked at $242 in Q1 2026.
  • 16 funds tracked by Wall St. Rank held Moolec Science SA Warrant as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.